Search research articles
Contact Us
Filters
Showing results (51-60 of 281) with videos related to
Page
of 29
Sort By:
Cancer Research
|
August 3, 2007
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells
Federica Saletta, Giuseppe Matullo, Maurizio Manuguerra, et al.
Human Mutation
|
November 28, 2013
Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels
Emily Hannah Crowley, Sabrina Arena, Simona Lamba, et al.
Seminars in Cancer Biology
|
April 13, 2021
Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
Pietro Andrei, Paolo Battuello, Gaia Grasso, et al.
Cancer Discovery
|
October 9, 2014
Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution
Sandra Misale, Federica Di Nicolantonio, Andrea Sartore-Bianchi, et al.
Cancer Research
|
September 19, 2007
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers
Sabrina Arena, Claudio Isella, Miriam Martini, et al.
Plos One
|
September 15, 2010
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas
Vincenzo Corbo, Rossana Ritelli, Stefano Barbi, et al.
Nature
|
August 29, 2002
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
Harith Rajagopalan, Alberto Bardelli, Christoph Lengauer, et al.
Molecular Oncology
|
June 11, 2014
Acquired resistance to EGFR-targeted therapies in colorectal cancer
Beth O Van Emburgh, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Molecular Oncology
|
December 7, 2018
Early-onset colorectal cancer in young individuals
Gianluca Mauri, Andrea Sartore-Bianchi, Antonio-Giampiero Russo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2020
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology
Ozge Gumusay, Pietro Paolo Vitiello, Chiara Wabl, et al.
Page
of 29
Search research articles
Search
Showing results (51-60 of 281) with videos related to
Sort By:
Page
of 29
Cancer Research
|
August 3, 2007
Exposure to the tobacco smoke constituent 4-aminobiphenyl induces chromosomal instability in human cancer cells
Federica Saletta, Giuseppe Matullo, Maurizio Manuguerra, et al.
Human Mutation
|
November 28, 2013
Targeted knock-in of the polymorphism rs61764370 does not affect KRAS expression but reduces let-7 levels
Emily Hannah Crowley, Sabrina Arena, Simona Lamba, et al.
Seminars in Cancer Biology
|
April 13, 2021
Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
Pietro Andrei, Paolo Battuello, Gaia Grasso, et al.
Cancer Discovery
|
October 9, 2014
Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution
Sandra Misale, Federica Di Nicolantonio, Andrea Sartore-Bianchi, et al.
Cancer Research
|
September 19, 2007
Knock-in of oncogenic Kras does not transform mouse somatic cells but triggers a transcriptional response that classifies human cancers
Sabrina Arena, Claudio Isella, Miriam Martini, et al.
Plos One
|
September 15, 2010
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas
Vincenzo Corbo, Rossana Ritelli, Stefano Barbi, et al.
Nature
|
August 29, 2002
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status
Harith Rajagopalan, Alberto Bardelli, Christoph Lengauer, et al.
Molecular Oncology
|
June 11, 2014
Acquired resistance to EGFR-targeted therapies in colorectal cancer
Beth O Van Emburgh, Andrea Sartore-Bianchi, Federica Di Nicolantonio, et al.
Molecular Oncology
|
December 7, 2018
Early-onset colorectal cancer in young individuals
Gianluca Mauri, Andrea Sartore-Bianchi, Antonio-Giampiero Russo, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2020
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology
Ozge Gumusay, Pietro Paolo Vitiello, Chiara Wabl, et al.
Page
of 29